Report
Guy Sips

Biotalys 1H25 underscores its prudent and cost-efficient operating strategy

Biotalys' 1H25 financials, including a cash position of €15.7m at period-end, underscore its disciplined and cost-conscious strategy, providing a financial runway through May 2026. We maintain our Buy and € 6.1 Target Price.
Underlying
BIOTALYS NV

Provider
KBC Securities
KBC Securities

We are a financial services provider for several types of professional clients, each with distinct needs.

 

Analysts
Guy Sips

Other Reports on these Companies
Other Reports from KBC Securities

ResearchPool Subscriptions

Get the most out of your insights

Get in touch